{"id":"prethcamide","rwe":[],"tags":[{"label":"prethcamide","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"R07AB06","category":"atc"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"gycoren","offLabel":[],"synonyms":["prethcamide","gycoren","miconen","micoren"],"timeline":[],"approvals":[],"brandName":"Gycoren","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"prethcamide","explanation":"Imagine your body's cells have locks on them, and Gycoren has a key that fits into those locks. When it binds to the lock, it triggers a response that helps to treat a particular condition. This is a simplified explanation of how Gycoren works at a molecular level.","oneSentence":"Gycoren works by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Gycoren's exact mechanism of action is not specified, but as a prethcamide, it is likely to modulate ion channels or receptors to produce its therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4333","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=prethcamide","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:25:24.914045","biosimilars":[],"competitors":[{"drugName":"doxapram","drugSlug":"doxapram","fdaApproval":"1965-06-23","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"prethcamide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"doxapram","brandName":"doxapram","genericName":"doxapram","approvalYear":"1965","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"41A1FCW148","UMLSCUI":"C0071957","ChEMBL_ID":"CHEMBL3833302","DRUGBANK_ID":"DB13447","PUBCHEM_CID":"71672","MESH_SUPPLEMENTAL_RECORD_UI":"C100196"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"R07AB06","allCodes":["R07AB06"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Gycoren is a small molecule modality composed of two related drugs, cropropamide and crotethamide. It is a respiratory stimulant sold under the brand name Micoren, which was developed by Ciba-Geigy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}